基于基于的纳米材料的癌症诊断和治疗平台
Jia Fei1, Yanyan Liu2, Ya Zeng1
1Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuhai, China.
Frontiers in bioengineering and biotechnology
|March 18, 2024
概括
基于的纳米材料 (MnNMs) 提供先进的癌症诊断和治疗. 这些多功能材料改善了瘤成像,并通过响应瘤微环境,实现了向治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症仍然是一个重大的全球健康挑战,需要新的诊断和治疗策略.
- 基于的纳米材料 (MnNMs) 正因其在癌症研究中的独特特性而受到关注.
研究的目的:
- 审查用于癌症诊断和治疗的基于的纳米材料的最新进展.
- 探索MnNMs的潜在临床应用,挑战和未来方向.
主要方法:
- 在癌症成像和治疗中对MnNMs研究的文献综述.
- 分析MnNM的特性,包括对比度增强和TME响应.
- 讨论当前的局限性和未来的研究前景.
主要成果:
- MnNMs作为MRI,PAI和NIR-FL的有效对比剂,增强瘤可视化.
- MnNMs对瘤微环境表现出反应性,为向癌症治疗铺平了道路.
- 在利用MnNMs进行精确瘤检测和定位方面取得了显著进展.
结论:
- 基于的纳米材料在综合癌症诊断和治疗方面非常有前途.
- 需要进一步的研究来克服挑战,并实现MnNMs的全部临床潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


